Carter Bankshares (CARE)
(Delayed Data from NSDQ)
$11.54 USD
-0.01 (-0.09%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $11.48 -0.06 (-0.52%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.54 USD
-0.01 (-0.09%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $11.48 -0.06 (-0.52%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Zacks News
Cambridge (CATC) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Cambridge (CATC) delivered earnings and revenue surprises of -2.86% and 1.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Blue Foundry Bancorp (BLFY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Blue Foundry Bancorp (BLFY) delivered earnings and revenue surprises of 7.14% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Meets Q3 Earnings Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 0% and 1.59%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Equity Bancshares (EQBK) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Equity Bancshares (EQBK) delivered earnings and revenue surprises of 5.26% and 2.30%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of -61.29% and 29.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter Bankshares, Inc. (CARE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 9.68% and 2.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Bridgewater (BWB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Bridgewater (BWB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: What to Know Ahead of Q1 Release
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Carter Bankshares, Inc. (CARE) Could Beat Earnings Estimates Again
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Carter Bankshares, Inc. (CARE) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 1.64% and 6.61%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business First (BFST) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Business First (BFST) delivered earnings and revenue surprises of 8.20% and 3.86%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Best Value Stocks to Buy for December 28th
by Zacks Equity Research
CARE, ADT and MUSA made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 28, 2022.
Is Carter Bankshares (CARE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Carter Bankshares, Inc. (CARE) Loses 9.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Is Carter Bankshares (CARE) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Carter Bankshares, Inc. (CARE) and Commerzbank AG (CRZBY) have performed compared to their sector so far this year.
Synchrony (SYF), Dutch Unveil Advanced Pet Insurance Plan
by Zacks Equity Research
Synchrony Financial (SYF) partners with Dutch to roll out an enhanced pet insurance plan for the latter's customers and meet pet care needs.
Why Carter Bankshares (CARE) Stock Might be a Great Pick
by Zacks Equity Research
Carter Bankshares (CARE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights Archer Daniels Midland, Carter Bankshares, W.R. Berkley, Lamb Weston and AeroVironment
by Zacks Equity Research
Archer Daniels Midland, Carter Bankshares, W.R. Berkley, Lamb Weston and AeroVironment are included in this Analyst Blog.
5 Solid Stocks to Play a Topsy-Turvy Wall Street
by Tirthankar Chakraborty
With U.S. stocks wavering, it's prudent to invest in risk-adjusted stocks like Archer Daniels Midland (ADM), Carter Bankshares (CARE), W.R. Berkley (WRB), Lamb Weston (LW) and AeroVironment (AVAV) for better returns.
Earnings Estimates Moving Higher for Carter Bankshares, Inc. (CARE): Time to Buy?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Carter Bankshares, Inc. (CARE) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 15.69% and 8.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
First Bank (FRBA) Beats Q3 Earnings Estimates
by Zacks Equity Research
First Bank (FRBA) delivered earnings and revenue surprises of 1.96% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?